期刊文献+

双氰胺熔点对照品熔点差异分析 被引量:3

Study on difference of melting point of dicyanodiamide reference substances
原文传递
导出
摘要 目的:探究中国药典和世界卫生组织双氰胺熔点对照品熔点差异的原因。方法:采用差示扫描量热分析(DSC)和热重/差热同步分析(TGA/SDTA)研究双氰胺熔点对照品的熔融过程,DSC升温速率10℃·min-1,干燥气N2流速50 m L·min-1,TGA/SDTA升温速率20℃·min-1,干燥气N2流速25 m L·min-1;并进一步通过HPLC法分析熔融前、中、后的样品。结果:差示扫描量热分析和热重/差热同步分析发现3个对照品的热力学行为基本一致,提示熔融后期可能已经热降解;HPLC法进一步证实双氰胺的熔融过程伴有部分降解。结论:热稳定性可能是造成中国药典和世界卫生组织双氰胺熔点对照品熔点差异的原因,双氰胺继续作为熔点对照品值得商榷。 Objective: To study the causes for difference of the melting point of dicyanodiamide reference substances( for melting point use) from Chinese pharmacopoeia( Ch P) and the World Health Organization( WHO).Methods: The melting process of reference substances was explored by the method of differential scanning calorimetry( DSC) and thermogravimetric / differential thermal analysis( TGA / SDTA). In the experiments of DSC and TGA / SDTA,the heating rates were 10 ℃ ·min^-1and 20 ℃ ·min^-1; and the gas flow rates of nitrogen were 50 m L·min^-1and 25 m L·min^-1,respectively. In addition,samples before,during and after melting were analyzed by HPLC successively. Results: Refering to the methods of DSC and TGA / SDTA,the thermal behaviors were similar for three dicyanodiamide reference substances from Ch P and WHO,indicating that degradation might occur at late stage of melting. By means of HPLC method,partial degradation was proved to exsit in the course of melting.Conclusion: Thermal stability may be the cause for difference of the melting point of dicyanodiamide reference substances from Ch P and WHO,and the use of dicyanodiamide as the reference substance for melting point needs to be further studied.
出处 《药物分析杂志》 CAS CSCD 北大核心 2015年第1期151-153,共3页 Chinese Journal of Pharmaceutical Analysis
基金 国家质量监督检验检疫总局公益性行业科研专项(20124244008-10) "重大新药创制"科技重大专项(215ZX09303001)
关键词 双氰胺 对照品 熔点 热稳定性 差示扫描量热分析 热重/差热同步分析 高效液相色谱 dicyanodiamide reference substances melting point thermal stability DSC TGA / SDTA HPLC
  • 相关文献

参考文献9

二级参考文献26

  • 1潘仙华,毛海舫,郎希红.Ⅰ型氯吡格雷硫酸氢盐的合成及晶型转换[J].精细化工,2006,23(12):1221-1226. 被引量:15
  • 2谢沐风.如何建立高效液相色谱法测定有关物质的方法[J].中国医药工业杂志,2007,38(1):45-48. 被引量:62
  • 3中国药典[S].2010:34.
  • 4欧洲药典[S].7.0版.2011:2151-2153.
  • 5Williams RL.2000-2005 reference standards committee of the USP council of experts and its advisory panel, USP staff and consultant.Official USP reference materials:metrology concepts, overview, and scientific issues and opportunities[J].J Pharm Biomed Anal, 2006, 40(1):3.
  • 6Argentine MD, Owens PK, Olsen BA.Strategies for the investigation and control of process-related impurities in drug substances[J].Adv Drug Deliv Rev, 2007, 59(1):12.
  • 7YAN Hong(颜虹).Medical Statistics(医学统计学)[M].Beijing(北京):People's Medical Publishing House(人民卫生出版社), 2005.269.
  • 8日本药局方[s].第16版.16:51-52.
  • 9美国药典[S].35版.
  • 10英国药典[S].2011年版.

共引文献9

同被引文献49

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部